Abbott Laboratories

Finance

Stocks making the biggest moves midday: Adobe, Ulta Beauty, Insulet, Klarna, Once Upon a

Check out some of the companies making the biggest moves midday: Adobe — The software giant saw shares tumble more

Read More
Finance

Stocks making the biggest moves midday: Nvidia, Exact Sciences, Walmart, Strategy, Regeneron

Check out the companies making headlines in midday trading: Nvidia — The chipmaker fell nearly 2%, reversing earlier gains after

Read More
Earnings

Danaher gives investors reasons to stick around, sending beaten-up shares flying

Danaher shares soared on Tuesday after the supplier of tools and equipment to drugmakers and hospitals provided an upbeat initial

Read More
Earnings

What Taiwan Semi’s blowout quarter means for these 2 portfolio chip stocks

Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a

Read More
Earnings

Abbott’s quarter disappoints again: We’re downgrading it and considering what to do next

Shares of Abbott Laboratories fell 3% on Wednesday after the diversified health-care company delivered another less-than-stellar quarter. Revenue in the

Read More
Earnings

Abbott stock fell victim to an old earnings season truth: It’s all about the guidance

Shares of Abbott Laboratories fell Thursday after the diversified health-care company delivered a solid second quarter but left investors disappointed

Read More
Earnings

Here are the 2 big things we’re watching in the stock market this week

President Donald Trump’s pause on sweeping global tariffs while keeping the pressure on China was good for a glorious, one-day

Read More
Earnings

Our 2 chip stocks are the portfolio’s biggest winners in one of Wall Street’s most volatile

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time

Read More

Get The Latest Investing Tips
Straight to your inbox

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.

Thank you for subscribing.

Something went wrong.